TriangleNCT00557193 · OUTCOME
Percent Probability of Event Free Survival (EFS) by MRD Status and Treatment Arm
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- Measure
- NUMBER
- Unit
- percent probability
- Interval / dispersion
- 90% Confidence Interval
- Time frame
- 3 Years from end of Induction)
What was measured
Three-year EFS estimates and 90% CI will be reported by treatment arm and end-induction MRD status.
Analysis population: Patients who had data collected
Groups in this outcome
Arm A (MRD Negative)
Arm A, standard risk MLL-G
Arm A (MRD Positive)
Arm A, standard risk MLL-G
Arm B (MRD Negative)
Arm B, IR/HR MLL-R chemotherapy
Arm B (MRD Positive)
Arm B, IR/HR MLL-R chemotherapy
Arm C (MRD Negative)
Arm C, IR/HR MLL-R chemotherapy and lestaurtinib
Arm C (MRD Positive)
Arm C, IR/HR MLL-R chemotherapy and lestaurtinib
| Group | Source count |
|---|---|
| Arm A (MRD Negative) | 43 |
| Arm A (MRD Positive) | 8 |
| Arm B (MRD Negative) | 19 |
| Arm B (MRD Positive) | 22 |
| Arm C (MRD Negative) | 27 |
| Arm C (MRD Positive) | 37 |
Reported measurements
Source class 1
| Group | Value | Spread | Lower | Upper | Comment |
|---|---|---|---|---|---|
| Arm A (MRD Negative) | 86.05 | Not reported | 77.36 | 94.74 | Not reported |
| Arm A (MRD Positive) | 87.5 | Not reported | 68.27 | 100 | Not reported |
| Arm B (MRD Negative) | 47.37 | Not reported | 28.53 | 66.21 | Not reported |
| Arm B (MRD Positive) | 22.73 | Not reported | 8.04 | 37.42 | Not reported |
| Arm C (MRD Negative) | 51.85 | Not reported | 36.03 | 67.67 | Not reported |
| Arm C (MRD Positive) | 27.03 | Not reported | 13.61 | 40.45 | Not reported |
Complete source fields
- classes
- categories
- measurements
- group Id
- OG000
- lower Limit
- 77.36
- upper Limit
- 94.74
- value
- 86.05
- group Id
- OG001
- lower Limit
- 68.27
- upper Limit
- 100
- value
- 87.5
- group Id
- OG002
- lower Limit
- 28.53
- upper Limit
- 66.21
- value
- 47.37
- group Id
- OG003
- lower Limit
- 8.04
- upper Limit
- 37.42
- value
- 22.73
- group Id
- OG004
- lower Limit
- 36.03
- upper Limit
- 67.67
- value
- 51.85
- group Id
- OG005
- lower Limit
- 13.61
- upper Limit
- 40.45
- value
- 27.03
- denoms
- counts
- group Id
- OG000
- value
- 43
- group Id
- OG001
- value
- 8
- group Id
- OG002
- value
- 19
- group Id
- OG003
- value
- 22
- group Id
- OG004
- value
- 27
- group Id
- OG005
- value
- 37
- units
- Participants
- description
- Three-year EFS estimates and 90% CI will be reported by treatment arm and end-induction MRD status.
- dispersion Type
- 90% Confidence Interval
- groups
- description
- Arm A, standard risk MLL-G
- id
- OG000
- title
- Arm A (MRD Negative)
- description
- Arm A, standard risk MLL-G
- id
- OG001
- title
- Arm A (MRD Positive)
- description
- Arm B, IR/HR MLL-R chemotherapy
- id
- OG002
- title
- Arm B (MRD Negative)
- description
- Arm B, IR/HR MLL-R chemotherapy
- id
- OG003
- title
- Arm B (MRD Positive)
- description
- Arm C, IR/HR MLL-R chemotherapy and lestaurtinib
- id
- OG004
- title
- Arm C (MRD Negative)
- description
- Arm C, IR/HR MLL-R chemotherapy and lestaurtinib
- id
- OG005
- title
- Arm C (MRD Positive)
- param Type
- NUMBER
- population Description
- Patients who had data collected
- reporting Status
- POSTED
- time Frame
- 3 Years from end of Induction)
- title
- Percent Probability of Event Free Survival (EFS) by MRD Status and Treatment Arm
- type
- SECONDARY
- unit Of Measure
- percent probability
Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0
Preserved source evidence · Not medical advice